Sex-Biased Aging Effects on Ig Somatic Hypermutation Targeting

• Published in: The Journal of immunology (1950) Vol. 206; no. 1; pp. 101 - 108
• Main Authors: Cui, Ang, Chawla, Daniel G, Kleinstein, Steven H
• Format: Journal Article
• Language: English
• Published: United States 01.01.2021
• Subjects: Adult; Aged; Aged, 80 and over; Aging - immunology; B-Lymphocytes - immunology; DNA Repair - genetics; Female; Humans; Immunity, Humoral - physiology; Immunoglobulins - genetics; Male; Middle Aged; Mutation - genetics; Sex Characteristics; Sex Factors; Somatic Hypermutation, Immunoglobulin; Young Adult
• ISSN: 0022-1767; 1550-6606; 1550-6606
• DOI: 10.4049/jimmunol.2000576

Aged individuals, particularly males, display an impaired level of Ab response compared with their younger counterparts, yet the molecular mechanisms responsible for the discrepancy are not well understood. We hypothesize that some of this difference may be linked to B cell somatic hypermutation (SHM) targeting, including error-prone DNA repair activities that are crucial to Ab diversification. To examine the effects of aging on SHM targeting, we analyzed B cell Ig repertoire sequences from 27 healthy male and female human subjects aged 20–89. By studying mutation patterns based on 985,069 mutations obtained from 123,415 sequences, we found that the SHM mutability hierarchies on microsequence motifs (i.e., SHM hot/cold spots) are mostly consistent between different age and sex groups. However, we observed a lower frequency in mutations involving Phase II SHM DNA repair activities in older males, but not in females. We also observed, from a separate study, a decreased expression level of DNA mismatch repair genes involved in SHM in older individuals compared with younger individuals, with larger fold changes in males than in females. Finally, we showed that the balance between Phase I versus Phase II SHM activities impacts the resulting Ig phenotypes. Our results showed that the SHM process is altered in some older individuals, providing insights into observed clinical differences in immunologic responses between different age and sex groups.